These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 14693272)
1. Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin. Pagliaro LC; Keyhani A; Liu B; Perrotte P; Wilson D; Dinney CP Urol Oncol; 2003; 21(6):456-62. PubMed ID: 14693272 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022 [TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines. Parker LP; Wolf JK; Price JE Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma. Weinrib L; Li JH; Donovan J; Huang D; Liu FF Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene. Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183 [TBL] [Abstract][Full Text] [Related]
6. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model. Miyake H; Hara I; Hara S; Arakawa S; Kamidono S Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer. Miyake H; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S Anticancer Res; 1998; 18(4C):3087-92. PubMed ID: 9713515 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Miyake H; Hanada N; Nakamura H; Kagawa S; Fujiwara T; Hara I; Eto H; Gohji K; Arakawa S; Kamidono S; Saya H Oncogene; 1998 Feb; 16(7):933-43. PubMed ID: 9484785 [TBL] [Abstract][Full Text] [Related]
9. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Li JH; Lax SA; Kim J; Klamut H; Liu FF Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):607-16. PubMed ID: 10078646 [TBL] [Abstract][Full Text] [Related]
10. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells. Ruifa H; Liwei L; Binxin L; Ximing L Urol Int; 2006; 77(4):355-61. PubMed ID: 17135787 [TBL] [Abstract][Full Text] [Related]
11. p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo. Kralj M; Pavelić J J Cancer Res Clin Oncol; 2003 Aug; 129(8):463-71. PubMed ID: 12884025 [TBL] [Abstract][Full Text] [Related]
12. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells. Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy for bladder cancer using adenoviral vector. Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547 [TBL] [Abstract][Full Text] [Related]
14. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099 [TBL] [Abstract][Full Text] [Related]
15. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents. Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines. Li JH; Li P; Klamut H; Liu FF Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin. Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970 [TBL] [Abstract][Full Text] [Related]
18. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line. Qi V; Weinrib L; Ma N; Li JH; Klamut H; Liu FF Int J Hyperthermia; 2001; 17(1):38-47. PubMed ID: 11212879 [TBL] [Abstract][Full Text] [Related]
19. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines. Watanabe J; Nishiyama H; Matsui Y; Ito M; Kawanishi H; Kamoto T; Ogawa O Oncogene; 2006 Apr; 25(17):2500-8. PubMed ID: 16518417 [TBL] [Abstract][Full Text] [Related]
20. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Ala-aho R; Grénman R; Seth P; Kähäri VM Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]